TotalMarketCap

BioLineRx

BLRXNasdaq IsraelHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$8.801 M

$1.77 -5.71%

Close of 6 Nov 2026

As of 6 Nov 2026, BioLineRx (BLRX) has a market capitalization of $8.80M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

2,610,814,390

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #421Curanex PharmaceuticalsCURX$9.06M
  2. #422BullFrog AIBFRG$9.02M
  3. #423BioLineRxBLRX$8.80M
  4. #424Lexaria BioscienceLEXX$8.78M
  5. #425CalciMedicaCALC$8.71M

What if BioLineRx were worth as much as…

Open the what-if tool →

Gold $28.2T

$5,672,087

Per share 3,208,194× higher

Bitcoin $1.53T

$306,906.74

Per share 173,590× higher

Apple $5.02T

$1,007,546

Per share 569,879× higher

Or at a round number

$20.0M$50.0M$100.0M$200.0M

Where these numbers come from

Share counts and financials for BioLineRx are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.